Article Information
History
- January 22, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Prashant Dogra1,
- Eugene J. Koay2,
- Zhihui Wang1,
- Farhaan S. Vahidy3,4,
- Mauro Ferrari5,6,
- Renata Pasqualini7,8,
- Wadih Arap7,9,
- Marc L. Boom10,
- H. Dirk Sostman11,12,13 and
- Vittorio Cristini1,*
- 1Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, Texas, USA
- 2Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 3Center for Outcomes Research, Houston Methodist Research Institute, Houston, Texas
- 4Houston Methodist Neurological Institute, Houston Methodist, Houston, Texas
- 5Department of Pharmaceutics, University of Washington, Seattle, Washington, USA
- 6Dompé X-Therapeutics, San Mateo, California, USA
- 7Rutgers Cancer Institute of New Jersey, Newark, NJ, USA
- 8Department of Radiation Oncology, Division of Cancer Biology, Rutgers New Jersey Medical School, Newark, NJ, USA
- 9Department of Medicine, Division of Hematology/Oncology, Rutgers New Jersey Medical School, Newark, NJ, USA
- 10Department of Medicine, Houston Methodist, Houston, Texas
- 11Weill Cornell Medicine, New York, NY, USA
- 12Houston Methodist Research Institute, Houston, TX, USA
- 13Houston Methodist Academic Institute, Houston, TX, USA
- ↵*Correspondence should be sent to: Vittorio Cristini, Ph.D.
, Professor and Chairman, Mathematics in Medicine Program, The Houston Methodist Research Institute Professor of Physiology, Biophysics and Systems Biology, Cornell Medical School Adjunct Professor of Imaging Physics, MD Anderson Cancer Center, vcristini{at}houstonmethodist.org
Posted January 22, 2021.
